Combinatorial RNAi for quantitative protein network analysis

The elucidation of cross-talk events between intersecting signaling pathways is one main challenge in biological research. The complexity of protein networks, composed of different pathways, requires novel strategies and techniques to reveal relevant interrelations. Here, we established a combinatorial RNAi strategy for systematic single, double, and triple knockdown, and we measured the residual mRNAs and proteins quantitatively by quantitative real-time PCR and reverse-phase protein arrays, respectively, as a prerequisite for data analysis. Our results show that the parallel knockdown of at least three different genes is feasible while keeping both untargeted silencing and cytotoxicity low. The technique was validated by investigating the interplay of tyrosine kinase receptor ErbB2 and its downstream targets Akt-1 and MEK1 in cell invasion. This experimental approach combines multiple gene knockdown with a subsequent quantitative validation of reduced protein expression and is a major advancement toward the analysis of signaling pathways in systems biology.

[1]  L. Lim,et al.  Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. , 2006, RNA.

[2]  M. Gilcrease,et al.  Integrin signaling in epithelial cells. , 2007, Cancer letters.

[3]  Tyra G. Wolfsberg,et al.  Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Yokoi,et al.  Intraductal spread of invasive breast carcinoma has a positive correlation with c‐erb B‐2 overexpression and vascular invasion , 1999, Cancer.

[5]  Joshua LaBaer,et al.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Braun,et al.  ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. , 2001, Cancer research.

[7]  W. Marshall,et al.  Analysis of Clathrin-mediated Endocytosis of Epidermal Growth Factor Receptor by RNA Interference*[boxs] , 2004, Journal of Biological Chemistry.

[8]  Zuoshang Xu,et al.  Multiple shRNAs expressed by an inducible pol II promoter can knock down the expression of multiple target genes. , 2006, BioTechniques.

[9]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[10]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[11]  C. Der,et al.  Molecular Basis for Rho GTPase Signaling Specificity , 2004, Breast Cancer Research and Treatment.

[12]  H. Wätzig,et al.  Precision and variance components in quantitative gel electrophoresis , 2005, Electrophoresis.

[13]  K. Keyomarsi,et al.  Anti-HER2 Antibody Trastuzumab Inhibits CDK2-Mediated NPAT and Histone H4 Expression via PI3K Pathway , 2006, Cell cycle.

[14]  W. Zhang,et al.  The signaling network of tumor invasion. , 2005, Histology and histopathology.